The human mind and body respond to stress 1 , a state of perceived threat to homeostasis, by activating the sympathetic nervous system and secreting the catecholamines adrenaline and noradrenaline in the 'fight-or-flight' response. The stress response is generally transient because its accompanying effects (for example, immunosuppression, growth inhibition and enhanced catabolism) can be harmful in the long term 2 . When chronic, the stress response can be associated with disease symptoms such as peptic ulcers or cardiovascular disorders 3 , and epidemiological studies strongly indicate that chronic stress leads to DNA damage 4, 5 . This stress-induced DNA damage may promote ageing 6 , tumorigenesis 4, 7 , neuropsychiatric conditions 8,9 and miscarriages 10 . However, the mechanisms by which these DNA-damage events occur in response to stress are unknown. The stress hormone adrenaline stimulates b 2 -adrenoreceptors that are expressed throughout the body, including in germline cells and zygotic embryos 11 . Activated b 2 -adrenoreceptors promote Gs-protein-dependent activation of protein kinase A (PKA), followed by the recruitment of b-arrestins, which desensitize G-protein signalling and function as signal transducers in their own right 12 . Here we elucidate a molecular mechanism by which b-adrenergic catecholamines, acting through both Gs-PKA and b-arrestin-mediated signalling pathways, trigger DNA damage and suppress p53 levels respectively, thus synergistically leading to the accumulation of DNA damage. In mice and in human cell lines, b-arrestin-1 (ARRB1), activated via b 2 -adrenoreceptors, facilitates AKT-mediated activation of MDM2 and also promotes MDM2 binding to, and degradation of, p53, by acting as a molecular scaffold. Catecholamine-induced DNA damage is abrogated in Arrb1-knockout (Arrb1 2/2 ) mice, which show preserved p53 levels in both the thymus, an organ that responds prominently to acute or chronic stress 1 , and in the testes, in which paternal stress may affect the offspring's genome. Our results highlight the emerging role of ARRB1 as an E3-ligase adaptor in the nucleus, and reveal how DNA damage may accumulate in response to chronic stress.
The human mind and body respond to stress 1 , a state of perceived threat to homeostasis, by activating the sympathetic nervous system and secreting the catecholamines adrenaline and noradrenaline in the 'fight-or-flight' response. The stress response is generally transient because its accompanying effects (for example, immunosuppression, growth inhibition and enhanced catabolism) can be harmful in the long term 2 . When chronic, the stress response can be associated with disease symptoms such as peptic ulcers or cardiovascular disorders 3 , and epidemiological studies strongly indicate that chronic stress leads to DNA damage 4, 5 . This stress-induced DNA damage may promote ageing 6 , tumorigenesis 4, 7 , neuropsychiatric conditions 8, 9 and miscarriages 10 . However, the mechanisms by which these DNA-damage events occur in response to stress are unknown. The stress hormone adrenaline stimulates b 2 -adrenoreceptors that are expressed throughout the body, including in germline cells and zygotic embryos 11 . Activated b 2 -adrenoreceptors promote Gs-protein-dependent activation of protein kinase A (PKA), followed by the recruitment of b-arrestins, which desensitize G-protein signalling and function as signal transducers in their own right 12 . Here we elucidate a molecular mechanism by which b-adrenergic catecholamines, acting through both Gs-PKA and b-arrestin-mediated signalling pathways, trigger DNA damage and suppress p53 levels respectively, thus synergistically leading to the accumulation of DNA damage. In mice and in human cell lines, b-arrestin-1 (ARRB1), activated via b 2 -adrenoreceptors, facilitates AKT-mediated activation of MDM2 and also promotes MDM2 binding to, and degradation of, p53, by acting as a molecular scaffold. Catecholamine-induced DNA damage is abrogated in Arrb1-knockout (Arrb1 2/2 ) mice, which show preserved p53 levels in both the thymus, an organ that responds prominently to acute or chronic stress 1 , and in the testes, in which paternal stress may affect the offspring's genome. Our results highlight the emerging role of ARRB1 as an E3-ligase adaptor in the nucleus, and reveal how DNA damage may accumulate in response to chronic stress.
As a model of chronic stress and prolonged stimulation of b 2 -adrenoreceptors 7, 13 , wild-type mice were infused for four weeks with either saline or the b 2 -adrenoreceptor-agonist isoproterenol, a synthetic analogue of adrenaline. First, we tested whether this regimen affects DNA damage by examining phosphorylation of histone H2AX (c-H2AX), one of the earliest indicators of DNA damage 14 .
Isoproterenol infusion leads to DNA damage in the thymus (Fig. 1a , left panel). Accumulation of DNA damage indicates compromised genome maintenance. To investigate the potential mechanism, we examined p53 levels in the thymus and found that isoproterenol infusion leads to decreased levels of p53 (Fig. 1a, right panel) . Consistent with the effects of isoproterenol in vivo, chronic stimulation of b 2 -adrenoreceptors with b-adrenergic catecholamines (isoproterenol, adrenaline or noradrenaline) leads to accumulation of DNA damage and a decrease in p53 levels in cultured U2OS cells ( Supplementary   Fig. 1a-c) , which endogenously express wild-type p53 and only the b 2 -subtype of b-adrenoreceptors ( Supplementary Fig. 2a-c) . Moreover, the p53 in these cells, as well as in all other cell lines used in these studies (fibroblasts and HEK-293 cells), was demonstrated to be functional by a variety of techniques ( Supplementary Fig. 3a-k) , and all cell lines endogenously expressed only the b 2 -subtype of b-adrenoreceptors ( Supplementary Fig. 2a-c) .
The isoproterenol-induced reduction in p53 levels results from p53 degradation, and is abolished by proteasome inhibition (Supplementary 
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) for 4 weeks. All bars represent mean 6 s.e.m. Histone, histone H2B; Iso, isoproterenol; WB, western blot. b, Isoproterenol-induced p53 reduction is dependent on nuclear export. This effect is specific to p53, in that another nuclear-cytosol shuttling molecule, FOXO3a, is not affected. LMB, leptomycin B. c, Preincubation with the b 2 -adrenoreceptor-selective antagonist ICI 118,551 (ICI) blocks isoproterenolinduced nuclear export of p53. Lactate dehydrogenase (LDH) is a cytosolic marker and histone is a nuclear marker. d, Isoproterenol stimulation leads to MDM2 phosphorylation at Ser 166, and is blocked by preincubation with ICI 118,551. e, Inhibition of the PI3K/AKT cascade abolishes isoproterenolstimulated decreases in p53 levels in U2OS cells. LY294002 is a PI3K inhibitor. f, Isoproterenol stimulation leads to Gs-independent, ARRB1-dependent MDM2 phosphorylation at Ser 166. Ns, not stimulated. Fig. 1d ). Because nuclear export of p53 has been shown to be involved in its degradation 15 , we examined p53 localization. Subcellular fractionation shows that isoproterenol stimulation leads to a decrease in nuclear p53 and an increase in cytosolic p53 ( Supplementary Fig. 1e , lower panels), thus, isoproterenol stimulation leads to p53 nuclear export. Immunocytochemical examination also shows increased levels of cytosolic p53 after isoproterenol stimulation ( Supplementary Fig. 1e , upper panels). Isoproterenol concentrations as low as 1 nM lead to p53 nuclear export, resulting in a decrease in total p53 levels ( Supplementary  Fig. 1f ). The importance of nuclear export in modulating p53 levels was investigated by treating cells with leptomycin B, an inhibitor of nuclear export. Leptomycin B pretreatment reverses isoproterenol-induced nuclear export of p53 (Fig. 1b) .
To examine whether isoproterenol-induced effects were specifically mediated by b 2 -adrenoreceptors, U2OS cells were stimulated with isoproterenol in the presence or absence of the subtype-selective b 2 -adrenoreceptor antagonist ICI 118,551. Preincubation with ICI 118,551 abrogates the isoproterenol-induced decrease in p53 levels (Fig. 1c) . During in vivo experiments, isoproterenol infusion leads to accumulation of DNA damage in the cerebellum, where b 2 -adrenoreceptors are the major subtype of b-adrenoreceptor 16 ( Supplementary Fig. 1g ). Furthermore, targeted disruption of the Adrb2 gene in mice markedly reduces accumulation of DNA damage upon isoproterenol infusion ( Supplementary Fig. 1h ). Taken together, these data indicate that stimulation of the b 2 -adrenoreceptor results in the nuclear export and degradation of p53 in a specific manner.
The E3 ligase MDM2 has been shown to have an important role in the regulation of p53 nuclear export and degradation 15 . Consistent with this, leptomycin B abrogates the ability of MDM2 to degrade p53 (ref. 15) . Before MDM2-mediated ubiquitination of p53, the phosphoinositide 3-kinase (PI3K)/AKT cascade phosphorylates MDM2, activating its E3 ligase function 17 . To examine whether stimulation of b 2 -adrenoreceptors leads to MDM2 phosphorylation via the PI3K/ AKT cascade, wild-type mouse embryonic fibroblasts (MEFs) were stimulated with isoproterenol in the presence or absence of ICI 118,551. Isoproterenol stimulation leads to MDM2 phosphorylation at Ser 166, an AKT phosphorylation site, and the effect is antagonized by ICI 118,551 ( Fig. 1d and Supplementary Fig. 1i ). To confirm that MDM2 is phosphorylated by the PI3K/AKT cascade upon isoproterenol stimulation, U2OS cells were stimulated with isoproterenol in the presence of either the PI3K inhibitor wortmannin or the AKT inhibitor AKTi. MDM2 phosphorylation is abolished by either wortmannin or AKTi (Supplementary Fig. 1j ). Furthermore, a PI3K inhibitor also abolishes catecholamine-induced lowering of p53 levels in the nucleus (Fig. 1e and Supplementary Fig. 1k ). The importance of MDM2 phosphorylation at Ser 166 was demonstrated by the overexpression of a phosphomimetic mutant at Ser 166 (MDM2-S166D) 17 , which facilitates the degradation of p53 when compared to wild-type MDM2 (Supplementary Fig. 1l ). These data implicate the PI3K/AKT cascade downstream of the b 2 -adrenoreceptor as a mediator of p53 stability through the phosphorylation of MDM2.
Upon activation of b 2 -adrenoreceptors, the PI3K/AKT cascade can be stimulated by both the Gs-PKA 18 and b-arrestin-mediated signalling pathways 19, 20 . To elucidate which pathway was involved, we examined the effect of b 2 -adrenoreceptor stimulation in wildtype MEFs in the presence of H-89, a PKA inhibitor, or in Arrb1 , MEFs (Fig. 1f, lane 7) . Furthermore, rescuing Arrb1 expression in Arrb1 2/2 MEFs restores the effects of isoproterenol stimulation ( Supplementary Fig. 1m ), and the effects of isoproterenol on MDM2 phosphorylation are abrogated in Arrb1 2/2 mice ( Supplementary Fig. 1n ). These data elucidate a Gsindependent, ARRB1-dependent signalling pathway that regulates the activation state of MDM2 through the PI3K/AKT cascade.
b-Arrestins can serve as adaptors for E3 ligases and their substrates 21 . Because we found that MDM2 activation by the PI3K/AKT cascade is an ARRB1-dependent event, we examined the binding between b-arrestins and p53, a known MDM2 substrate. In HEK-293 cells stably overexpressing ARRB1 or ARRB2, p53 binds preferentially to ARRB1, an isoform localized to both the cytosol and nucleus 22 , but not to ARRB2, which predominantly localizes to the cytosol [22] [23] [24] [25] ( Supplementary Fig. 4a ). Binding between these two molecules at 
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endogenous levels is also observed in HEK-293 cells and brain homogenates ( Fig. 2a and Supplementary Fig. 4b ). The binding seems to be direct, because purified ARRB1 tagged with glutathione-S-transferase (GST-ARRB1) binds to p53 in vitro (Fig. 2b) . To examine the effect of b 2 -adrenoreceptor stimulation on this complex, we treated untransfected HEK-293 cells, which endogenously express only the b 2 subtype of b-adrenoreceptors ( Supplementary Fig. 2b , c), with isoproterenol. Stimulation of b 2 -adrenoreceptors does not affect the binding of ARRB1 to p53 ( Supplementary Fig. 4c ). Subsequently, we mapped the binding sites in ARRB1 and p53 by performing sequential deletions, followed by immunoprecipitation from HEK-293 cells (Supplementary Fig. 4d , e). We identified the amino terminus of ARRB1 (amino acids 1-186) as critical for binding to p53. In p53, a domain comprising amino acids 101-186 is required for binding to ARRB1. Consistent with these results, a synthetic ARRB1-binding peptide (ARRB-BP), which binds to the N terminus of ARRB1 and induces a conformational change 26 , disrupts the interaction between ARRB1 and p53 ( Supplementary Fig. 4f ).
Co-immunoprecipitation experiments after subcellular fractionation show that more than 90% of the binding between ARRB1 and p53 occurs in the nucleus ( Supplementary Fig. 4g ). Additionally, confocal analysis reveals that endogenous ARRB1 and p53 co-localize in the nucleus (Fig. 2c ) and a ternary complex between ARRB1, MDM2 and p53 was observed in p53-null NCI-H1299 cells transfected with wild-type p53 ( Supplementary Fig. 4h ). The potential effects of nuclear ARRB1 on MDM2 binding to p53 were investigated in U2OS cells transfected with either Arrb1 or Arrb1-Q394L, in which a single amino acid, Gln 394, has been mutated to Leu to create a nuclear export signal in ARRB1 22, 23 . Overexpression of ARRB1 facilitates the binding of MDM2 to p53, enhancing basal b 2 -adrenoreceptorstimulated ARRB1 signalling (Fig. 2d) ; however, the effect is abolished with ARRB1-Q394L (Fig. 2e ). This result indicates that ARRB1 facilitates an MDM2-p53 interaction in the nucleus. The role of endogenous ARRB1 as a facilitator of MDM2-p53 complex formation under isoproterenol-stimulated conditions is further demonstrated in Arrb1 2/2 MEFs (Fig. 2f) , in which loss of ARRB1 prevents the increased interaction of MDM2 and p53 after isoproterenol stimulation, when compared to wild-type cells.
Next we examined whether ARRB1 expression affects p53 levels by comparing different clonal populations of wild-type and Arrb1
2/2
MEFs. Arrb1 2/2 MEFs show increased p53 levels ( Supplementary  Fig. 5a ). Furthermore, rescuing ARRB1 expression in Arrb1
MEFs decreases p53 levels in a dose-dependent manner (Fig. 3a) . Differences in p53 levels under basal conditions seem to be the result of decreased p53 ubiquitination in Arrb1 2/2 MEFs (Fig. 3b , lanes 1 and 3). Furthermore, consistent with b 2 -adrenoreceptor-induced degradation of p53, isoproterenol stimulation promotes p53 ubiquitination, but the effect is markedly decreased in Arrb1 2/2 MEFs (Fig. 3b , lanes 2 and 4). To address further whether ARRB1 facilitates the ubiquitination of p53 by MDM2, we conducted in vitro ubiquitination assays ( Supplementary Fig. 5b ). Addition of ARRB1 facilitates MDM2-mediated ubiquitination of p53 and the effect is abolished with ARRB-BP. Together, these data indicate that upon catecholamine stimulation, ARRB1 promotes the interaction of MDM2 and p53 by acting as an E3 ligase adaptor that facilitates ubiquitination of p53.
Cytosolic ARRB1 mediates catecholamine-induced activation of AKT and MDM2, whereas nuclear ARRB1 serves as an adaptor for MDM2-dependent ubiquitination of p53. Consistent with these results, isoproterenol stimulation leads to a lowering of p53 levels (Fig. 3c, lane 2) . By contrast, p53 levels remain constant in Arrb1
MEFs (Fig. 3c, lane 4) . Furthermore, rescuing ARRB1 expression in Arrb1 2/2 MEFs by transient transfection restores isoproterenolstimulated degradation of p53 (Fig. 3c, lane 6) , and suppression of ARRB1 by RNA interference results in suppression of isoproterenolstimulated MDM2-p53 complex formation, and a lowering of p53 levels in U2OS cells (Fig. 3d, e) .
To differentiate the cytosolic (catecholamine-induced MDM2 phosphorylation) and nuclear (E3 ligase adaptor) functions of ARRB1 in this cascade, a phosphomimetic mutant of MDM2 (MDM2-S166D) was co-transfected with either Arrb1 or Arrb1-Q394L into Arrb1
MEFs. This allowed us to focus on the nuclear function of ARRB1. Restoring ARRB1 expression with the wild type, but not with the Q394L mutant, facilitates the degradation of p53 ( Supplementary  Fig. 5c ). Consequently, it seems that although the cytoplasmic pool of ARRB1 is sufficient to activate MDM2 through the PI3K/AKT pathway, the nuclear pool of ARRB1 is required to act as an E3 ligase adaptor for MDM2 towards p53.
To examine this cascade in vivo, we examined the effects of catecholamine on p53 levels and accumulation of DNA damage in the thymus of Arrb1 2/2 mice. The mice were infused for four weeks with either saline or isoproterenol. In contrast to wild-type mice (Fig. 1a) , p53 levels are maintained upon isoproterenol infusion in Arrb1
mice, and accumulation of DNA damage is abrogated (Fig. 3f) .
We have observed that isoproterenol infusion leads to lowering of p53 levels, and have elucidated a molecular mechanism whereby MEFs were stimulated with 10 mM isoproterenol for 24 h. Cell lysates were immunoprecipitated with an anti-p53 antibody (FL-393) and analysed by immunoblotting with an anti-ubiquitin (P4D1) antibody. c, Isoproterenol stimulation leads to ARRB1-dependent p53 degradation. d, Reduction in ARRB1 levels induced by small hairpin RNA (shRNA) in U2OS cells. e, Suppression of ARRB1 suppresses isoproterenol-induced binding of MDM2 to p53 and restores p53 levels in U2OS cells. U2OS cells were treated with either control shRNA or ARRB1 shRNA for 72 h, followed by 24 h stimulation with 10 mM isoproterenol. f, Levels of p53 in isoproterenol-infused Arrb1 2/2 mice remain constant and there is no accumulation of DNA damage. Arrb1 2/2 mice (n 5 3-4 for each condition) were treated as in Fig. 1a . All bars represent mean 6 s.e.m.
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ARRB1 regulates MDM2-dependent degradation of p53 upon b 2 -adrenoreceptor stimulation. Next, we investigated further the effects of catecholamine-dependent p53 degradation on accumulation of DNA damage. To visualize the prevalence of DNA damage, we analysed the formation of c-H2AX foci in both wild-type and Arrb1
2/2
MEFs. After chronic stimulation with isoproterenol, there is an increase in the formation of c-H2AX foci (sevenfold) in wild-type MEFs, which is significantly reduced in Arrb1 2/2 MEFs (Fig. 4a , panels 2 and 4, and Supplementary Fig. 6a ). Moreover, rescuing ARRB1 expression in Arrb1 2/2 MEFs restores the accumulation of isoproterenol-induced c-H2AX foci (Fig. 4b, panels 5-8 , and Supplementary Fig. 6a) .
To examine how exposure to stress hormones initiates DNA damage, p53-null NCI-H1299 cells were chronically stimulated with isoproterenol. This leads to accumulation of DNA damage (Fig. 4c,  panels 1-8) , indicating that DNA damage is triggered by p53-independent mechanisms after isoproterenol stimulation. One of the prominent cascades leading to DNA damage is the generation of reactive oxygen species through Gs-PKA signalling 27 . Accordingly, accumulation of isoproterenol-induced DNA damage is suppressed by inhibition of PKA (Fig. 4d, lanes 1 and 3) . Consistent with the idea that ARRB1-mediated effects on DNA damage are due to altered p53 levels, rescuing p53 expression ( Supplementary Fig. 3l ) decreases isoproterenol-induced c-H2AX foci (Fig. 4c, panels 9-16; Fig. 4d , lanes 1 and 2) and the p53 effect is antagonized by co-expression of ARRB1 (Fig. 4c , panels 17-20, and Supplementary Fig. 6b ). These G-proteinmediated and ARRB1-mediated pathways may synergistically affect the accumulation of isoproterenol-induced DNA damage. Thus, combining PKA inhibition with rescue of p53 expression abrogates accumulation of DNA damage (Fig. 4d, lanes 1 and 4) . Catecholamineinduced lowering of p53 levels may lead to increased survival of cells containing DNA damage, owing to an impaired DNA damage checkpoint and repair cascade 28 . This would then facilitate accumulation of DNA damage. Accordingly, U2OS cells were irradiated with ultraviolet light after isoproterenol stimulation. Chronic stimulation leads to increased FOS expression, an indicator of cell survival and proliferation ( Supplementary Fig. 6c ). Because DNA damage occurs under these conditions, FOS expression leads to proliferation of cells that contain DNA damage. Taken together, these data indicate that Gs-PKA-dependent signalling, which leads to the generation of reactive oxygen species 27 , and ARRB1-dependent p53 degradation, which results in impaired DNA checkpoint and repair mechanisms 28 , synergistically lead to accumulation of DNA damage and consequently may have effects on genomic integrity.
DNA damage may promote rearrangements in chromosomes. To quantify the occurrence of catecholamine-induced rearrangements, we analysed inter-chromosomal rearrangements between Tcrg (the T-cellreceptor-c locus) and Tcrb (the T-cell-receptor-b locus) in thymocytes (see Methods and Supplementary Fig. 6d ). Both wild-type and Arrb1 2/2 mice were infused for four weeks with either saline or isoproterenol, and genomic DNA was isolated from the thymus. Consistent with the accumulation of DNA damage (Figs 1a, 3f ), isoproterenol infusion leads to an increase in these Tcr rearrangements in wild-type mice; however, the effects are no longer observed in Arrb1 2/2 mice ( Fig. 4e and Supplementary Fig. 6e ). This indicates that catecholamine-stresshormone-dependent accumulation of DNA damage promotes rearrangements in chromosomes.
Because chronic isoproterenol stimulation affects DNA damage and chromosomal rearrangements, we examined whether this cascade also affects genome integrity in the testes, in which paternal stress may affect the offspring's genome. Using the isoproterenol-infusion model of chronic stress 7, 13 , we observed that isoproterenol stimulation leads Total indicates PCR amplification of a non-specific locus (see Methods). f, Isoproterenol infusion leads to decreased p53 levels in the testes from wildtype, but not Arrb1 2/2 , mice. Wild-type and Arrb1 2/2 mice (n 5 5 for each condition) were treated as in Fig. 1a . All bars represent mean 6 s.e.m. g, Isoproterenol-infused mice develop chromosomal rearrangements in an ARRB1-dependent manner. Wild-type and Arrb1 2/2 mice were infused as in Fig. 1a . Genomic DNA from each organ was examined in an array-CGH. The data represent log 2 ratio plots (isoproterenol/saline) of genomic content in chromosome 4 (chr4, 105-130 Mb), comparing isoproterenol-infused mice with saline-infused mice of a same genotype. *, significance threshold of 1.0 3 10 27 (rank segmentation algorithm). The direction of isoproterenolinduced chromosomal gain (green arrow) or loss (red arrow) is indicated. Yellow highlights represent sites of isoproterenol-induced rearrangements. h, Schematic diagram of b 2 -adrenoreceptor (b 2 AR)-dependent regulation of DNA damage in response to prolonged secretion of catecholamines during chronic stress.
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to a lowering of p53 levels in the testes. The effects are abolished in Arrb1 2/2 mice (Fig. 4f) . To examine these phenomena in a genomewide context, we conducted an array-comparative genomic hybridization (array-CGH). In the same model of chronic stress 7, 13 , genomic DNA was isolated from the testes and thymus, which allowed us to eliminate any changes due to meiotic recombination by considering only rearrangements that occurred in both organs (see study design in Supplementary Fig. 6f ). These studies show that the only such rearrangement occurring upon isoproterenol-infusion results in a duplication of more than 1 megabase (Mb) in regions 4qD2.2 and 4qD1 in wild-type mice; however, these events are not observed in the testes from Arrb1 2/2 mice ( Fig. 4g and Supplementary Fig. 6f ). Quantitative PCR (qPCR) of the testicular genome from each mouse also confirms isoproterenol-induced duplication at 4qD2.2 in an ARRB1-dependent manner (Supplementary Fig. 6g ). Taken together, these data support the hypothesis that b 2 -adrenoreceptor-and ARRB1-dependent signalling regulates catecholamine-induced degradation of p53, thus leading to the accumulation of DNA damage in both somatic and germline cells (Fig. 4h) .
The stress response is conserved in mammals, and is probably required for survival. However, psychosocial stress in humans is not time-limited, because aspects of this type of stress response can be sustained over months or even years. This may lead to prolonged secretion of stress hormones and consequent adverse effects for the individual. Indeed, clinical studies have shown marked risk-reductions for prostate cancer, lung adenocarcinoma and Alzheimer's disease associated with chronic b-blocker (b-adrenoreceptor-antagonist) therapy 4, 29, 30 . It also seems plausible that such hormonal influences on DNA damage may not be limited to the b 2 -adrenoreceptors.
METHODS SUMMARY
Experimental procedures. Each experiment was repeated at least three times with comparable results, unless indicated otherwise. Cell culture conditions and treatments. Isoproterenol was prepared fresh for each experiment by dissolving bitartrate salt (Sigma) immediately before stimulation. To study chronic b-adrenergic effects, U2OS cells and MEFs were cultured until confluent, then stimulated with 10 mM isoproterenol for 24 h unless otherwise indicated. To study c-H2AX formation, cells were cultured until 40-50% confluent, then stimulated with 10 mM isoproterenol every 12 h for 3 days. To study phosphorylation of MDM2 at Ser 166 in MEFs, cells were serum-starved for 4 h, then stimulated with 10 mM isoproterenol for 1 h. H-89 (10 mM), leptomycin B (10 nM), ICI 118,551 (10 mM), wortmannin (100 nM), 5-(2-benzothiazolyl)-3-ethyl-2-(2-(methylphenylamino)ethenyl)-1-phenyl-1H-benzimidazolium iodide (AKTi, 1 mM) or LY294002 (10 mM, Sigma) were added to the media 30 min before stimulation with isoproterenol. Isoproterenol infusion. Mice were subcutaneously implanted with ALZET osmotic pumps to administer saline or isoproterenol (30 mg kg 21 d
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) continuously, dissolved in saline, for 28 days (mini-osmotic pump model 2004), following the manufacturer's procedure. After administration, animals were killed and the indicated organs were dissected out. All animals used in these studies were adult male mice of 8-12 weeks of age. Animals were handled according to approved protocols and animal welfare regulations of the Institutional Review Board at Duke University Medical Center.
METHODS
Reagents. Unless otherwise noted, chemicals were purchased from Sigma. Antibodies. Antibodies used were as follows, indicated WB for western blotting, IP for immunoprecipitation and CM for confocal microscopy. PARP-1 (WB, 1:500 dilution, Alexis Biochemicals). FOXO3a (WB, 1:500), MDM2 phosphorylated at Ser 166 (WB, 1:1,000), FOS (WB, 1:500), PUMA (WB, 1:500), p21 (WB, Plasmids. The MDM2-S166D plasmid 17 and p53 deletion constructs 33 and were gifts from M. C. Hung and S. H. Snyder, respectively. Plasmids encoding shRNAs against p53 (psiRNA-mp53 and psiRNA-hp53), and the control psiRNA-LucGL3, were purchased from InvivoGen. Experimental procedures. Each experiment was repeated at least three times with comparable results, unless indicated otherwise. Immunoblotting. SDS polyacrylamide gel electrophoresis (SDS-PAGE) was performed on 1.0-mm-thick NuPAGE 4-12% Bis-Tris gels (Invitrogen) and separated proteins were transferred to nitrocellulose membranes by semi-dry transfer, using trans-blot transfer medium (Bio-Rad). Blots were blocked with blocking buffer (5% skimmed milk in PBS with 0.02% Tween-20) before incubation at 4 uC overnight with primary antibodies, diluted in blocking buffer as described above. Blots were washed three times for 5 min each in PBS with 0.02% Tween-20, and then incubated with secondary antibodies in blocking buffer. Blots were washed three times for 5 min each in PBS with 0.02% Tween-20, and developed by SuperSignal West Pico/Femto solution (Pierce). Each protein band of interest on the immunoblot was quantified by densitometry using the GeneTools program (SynGene). Co-immunoprecipitation. Cells were lysed in a lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 0.1% CHAPS buffer, 0.1 mg ml 21 BSA, 1 mM PMSF and 1 mM EDTA, with Halt protease and phosphatase inhibitor cocktail (Pierce)), and homogenized by passing through a 28-gauge needle 20 times. Crude lysates were cleared of insoluble debris by centrifugation at 14,000g. Extra lysis buffer was added to 100-500 mg of cell lysate to bring samples to a total volume of 1 ml. Immunoprecipitating antibody (1-2 mg) was added and incubated on a rotator at 4 uC overnight. On the following day, 25 ml (50% slurry) of the appropriate TrueBlot IP beads (eBioscience) was added and incubated on a rotator at 4 uC for 1 h. The beads were washed five times with the lysis buffer and quenched with 30 ml of SDS sample buffer (32) . For detection of p53 ubiquitination (Fig. 3b) , 10 mM N-ethylmaleimide and 20 mM MG132 were added to the lysis buffer. Coimmunoprecipitation after cell fraction was conducted as previously described 34 . Briefly, cells were lysed in RIPA A buffer (0.3% Triton X-100, 50 mM Tris (pH 7.4) and 1 mM EDTA), with rotation at 4 uC for 30 min. Cell lysates were centrifuged at 14,000g for 10 min and the supernatant was used as the cytosolic fraction. The nuclear fraction was extracted from the pellet with RIPA B buffer (1% Triton X-100, 1% SDS, 50 mM Tris (pH 7.4), 500 mM NaCl and 1 mM EDTA), affinity-precipitated with the indicated antibodies, and subjected to SDS-PAGE. Subcellular fractionation. U2OS cells from a 10-cm plate were resuspended in 300 ml of buffer B (0.25 M sucrose, 10 mM Tris (pH 7.4), 10 mM MgCl 2 , 10 mM KCl, 1 mM DTT and protease inhibitor cocktail without EDTA) and homogenized with 150 strokes in a 1-ml dounce tissue grinder (Wheaton) using a tight pestle on ice. After centrifugation at 750g for 10 min, the supernatant was isolated to separate the cytosolic fraction. The pellet was washed twice with buffer B, and resuspended in 100-200 ml of buffer B. The suspension was analysed as the nuclear fraction. Cytosolic fractions and nuclei were also prepared by using Nuclei EZ prep nuclei isolation kit (Sigma), following the manufacturer's protocol, and comparable results were obtained. To detect the effects of PI3K inhibition by LY294002 on isoproterenol-induced p53 nuclear export, U2OS cells were preincubated with 10 mM LY294002 for 30 min, and then stimulated with 10 mM isoproterenol for 1 h. To detect the effects of nuclear export on decreased nuclear p53, U2OS cells were pre-incubated with 10 nM leptomycin B for 30 min, and then stimulated with 10 mM isoproterenol for 1 h. To prepare a total-cell extract, cell pellets were lysed in a lysis buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 0.1% CHAPS, 0.1 mg ml 21 BSA, 1 mM PMSF and 1 mM EDTA, with Halt protease and phosphatase inhibitor cocktail (Pierce)) and homogenized by passing through a 28-gauge needle 20 times. Crude lysates were cleared of insoluble debris by centrifugation at 20,000g. Cell culture conditions and treatments. Wild-type MEFs (passage number ,72), Arrb1 2/2 MEFs (passage number ,76) and Arrb2 2/2 MEFs (passage number ,49) were prepared according to the 3T3 protocol 35, 36 . Established MEF cultures and RAW264.7 cells were maintained in Dulbecco's modified Eagle medium (DMEM) with 10% FBS and 2 mM L-glutamine at 37 uC with a 5% CO 2 atmosphere in a humidified incubator. U2OS, HEK-293 and NCI-H1299 cells were maintained in modified Eagle medium (MEM) with 10% FBS and 2 mM L-glutamine, with the same conditions as above. U2OS and NCI-H1299 cells were transfected with FuGENE6 transfection reagent (Roche) following the manufacturer's protocol. For RNA interference for ARRB1, the vector system shRNA was used as previously described 37, 38 . Briefly, U2OS cells in 10-cm plates were transfected with either 10 mg control shRNA plasmid (59-ACGTGACACGTTCGGAGAATTGATATCCGTTC TCCGAACGTGTCACGTTT-39) or 10mg ARRB1 shRNA plasmid (59-ATTCT CCGCGCAGAAGGCTTT GATATCCG AGCCTTCTGCGCGGAGAATTT-39), and incubated for 72 h. HEK-293 cells and MEFs were transfected with lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. Briefly, 2 mg of DNA was dissolved in 35 ml of serum-and antibiotic-free medium per well, in a 6-well plate. Lipofectamine 2000 (10 ml) was mixed with 25 ml of serum-and antibiotic-free medium, and incubated for 5 min. The prepared DNA and lipofectamine 2000 solutions were mixed and the mixture was incubated for 20 min at 18-23 uC. During the incubation, normal cell-culture medium was replaced with serumand antibiotic-free medium. The transfection mixture was added to the cells in serum-free culture, and incubated overnight. On the following day, the medium was replaced with normal serum-and antibiotic-containing growth medium, and the cells were incubated for 48-72 h before testing.
Isoproterenol, epinephrine and norepinephrine were prepared fresh for each experiment by dissolving the bitartrate salts (Sigma) immediately before stimulation. To study chronic b-adrenergic effects, U2OS cells and MEFs were cultured until confluent, then stimulated with 10 mM isoproterenol for 24 h, unless otherwise indicated. To study c-H2AX formation, cells were cultured until 40-50% confluent, then stimulated with 10 mM isoproterenol every 12 h for 3 days. H-89 (10 mM), leptomycin B (10 nM), ICI 118,551 (10 mM), wortmannin (100 nM), 5-(2-benzothiazolyl)-3-ethyl-2-(2-(methylphenylamino)ethenyl)-1-phenyl-1H-benzimidazolium iodide (AKTi, 1 mM) or LY294002 (10 mM, Sigma) were added to the media 30 min before stimulation with isoproterenol. To study the effects of isoproterenol stimulation on cell proliferation after DNA damage, cells were ultraviolet-irradiated (50 J per m 2 ) and incubated for 6 h, followed by stimulation with 10 mM isoproterenol every 12 h for 3 days. Cell lysates were examined by immunoblotting for FOS, an indicator of cell survival and proliferation 39 . To study phosphorylation of MDM2 at Ser 166 in MEFs, cells were serum-starved for 4 h, then stimulated with 10 mM isoproterenol for 1 h. To study this phosphorylation event in U2OS cells, cells were serumstarved for 36 h, then stimulated with 10 mM isoproterenol for 10 min. In vitro ubiquitination assay. 
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(pH 7.4), 500 mM NaCl, 1% SDS, 1% Triton X-100 and 1 mM EDTA, with Halt protease and phosphatase inhibitor cocktail). Genomic DNA was prepared from dissected organ tissues by DNeasy blood & tissue kit (Qiagen), following the manufacturer's protocol. All animals used in these studies were adult male mice of 8-12 weeks of age. All mouse strains were backcrossed to the C57BL/6 background for $10 generations. Animals were handled according to approved protocols and animal welfare regulations of the Institutional Review Board at Duke University Medical Center. Quantitative real-time PCR (qPCR). qPCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) and StepOne Real-time PCR system (Applied Biosystems) following the manufacturer's protocol. To validate the array-CGH analysis, relative genomic content (copy number) was determined with the comparative C T (DDC T ) method 42 . GST pulldown assay. Wild-type rat Arrb1 or human MDM2 were subcloned into the pGEX4T1 vector and prepared according to the manufacturer's recommendations (Amersham Biosciences). The GST tag was cleaved with thrombin protease (Hematologic Technologies Inc.). p53 (1 nM) was co-incubated overnight with 10 nM of GST-ARRB1 or 10 nM of GST at 4 uC in 1 ml binding buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 0.1 mg ml 21 BSA and 10 mM D-myo-inositol 1,2,3,4,5,6-hexakisphosphate), and 20 ml of 50% glutathione-sepharose was then added to the mixture. The mixture was further incubated at 4 uC for 1 h with rotation. The beads were washed once with 1 ml binding buffer, separated by SDS-PAGE and analysed by immunoblotting. Immunofluorescence experiments. Immunofluoresence using confocal microscopy was carried out as previously described 43 . For detection of c-H2AX foci, we captured images of more than 20 fields per preparation, which were randomly chosen in a blind manner. Cells positive for c-H2AX foci in each field were tallied and added together to determine the percentage. The total number of cells was counted with 49,6-diamidino-2-phenylindole (DAPI) nuclear staining. For rescue experiments using the expression of RFP-ARRB1 (or RFP as a control) in MEFs, RFP-positive cells were counted for c-H2AX foci. For p53 rescue experiments in NCI-H1299 cells, RFP-Arrb1 (or RFP) and p53 were co-transfected in a 1:3 ratio. Detection of interchromosomal rearrangements between Tcrg and Tcrb. The trans-rearrangement between Tcrg and Tcrb loci were detected by nested PCR, using first the 'a' set of primers and then the 'b' set of primers, as previously described 44 ( Supplementary Fig. 6d ). The number of rearrangements is expressed as the reciprocal of the highest dilution of DNA yielding an amplified product (for example, the number of trans-rearrangements per 1.5 3 10 5 cells (1 mg of DNA) is 1,000, yielding an amplifiable fragment at a 1:1,000 dilution (1 ng of DNA)) 44 . DNA preparation. DNA was prepared from the testes and thymus by using the DNeasy blood & tissue kit (Qiagen) following the manufacturer's protocol. To enrich sperm from excised testis grafts, the testis was minced and the epithelial tissue, containing leydig and sertoli cells, was removed. Array-comparative genomic hybridization (Array-CGH). A tiling-path CGH array for the genome analysis in mouse (UCSC Build mm9) was designed and constructed by NimbleGen Systems (NimbleGen). The resulting array contained 720,000 probes with a median probe spacing of 3,537 base pairs. Probes were synthesized using an isothermal format (melting temperature 76 uC), and varied in length from 50 to 75 base pairs. Genomic DNA from five mice for each experimental condition was pooled and examined. Genomic DNAs (1 mg) from test (isoproterenol-treated) and reference (saline-treated) mice were differentially labelled with 59-Cy3 and 59-Cy5 random nonamers (TriLink Biotechnologies), respectively, and hybridized to the oligoarray for 72 h using the MAUI hybridization station (BioMicro Systems Inc.). Image-capture of the hybridized arrays for fluorescent intensity extraction was performed using a Genepix 4100A scanner (Molecular Dynamics) and normalized using Nimblescan v2.5 microarray software (Nimblegen) before importing into Nexus Copy-Number (BioDiscovery) for analysis. Array-CGH analysis. BioDiscovery's rank segmentation algorithm, which is similar to circular binary segmentation 45 , was used to identify genomic rearrangements. The significance threshold was set as 1.0 3 10
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. The calling algorithm used cluster values and defined log 2 thresholds of 60.2. We applied a cutoff of ten oligomer clones showing the same trend in copy-number change to define chromosomal rearrangements. Black lines in the plot indicate a 'cluster value', which is the median log-ratio value of all the probes in that region. Isoproterenol-induced rearrangements in the testes were determined, and identical rearrangements were detected in the thymus (see study design in Supplementary Fig. 6f ). Radioligand binding experiments. For ICI 118,551 and CGP 20712A affinity measurements, subtype-selective ligand affinities were determined from competition radioligand binding experiments, conducted according to previous works 46, 47 . Briefly, 25 mg of cell membranes, prepared via differential centrifugation, were resuspended in assay buffer (50 mM Tris-HCl (pH 7.4), 12.5 mM MgCl 2 , 2 mM EDTA and 1 mM ascorbic acid) containing 60 pM [ ) and concentrations of ICI 118,551 or CGP 20712A ranging from 1 mM to 1 pM. Nonspecific binding was determined in the presence of 10 mM propranolol. After incubation at 25 uC for 90 min, membranes were collected and washed via vacuum filtration (Brandel) and the bound radioactivity was quantified using a Packard Cobra gamma counter (Perkin Elmer). Equilibrium inhibition constant (K i ) values were calculated from nonlinear regression analysis (Graphpad) using the method in ref. 48 . p53 reporter assay. U2OS cells were transfected with the p53-luc reporter plasmid (Stratagene) in the presence of serum, using FuGENE6 transfection reagent (Roche). Three hours after the transfection, media were changed to serum-free media containing 100 mM ascorbic acid and appropriate concentrations of isoproterenol. Cells were incubated for 24 h and lysed in 31 passive lysis buffer (PLB, Promega). The firefly luciferase reporter was analysed with addition of luciferase assay reagent II (Promega). Chromatin immunoprecipitation assay (ChIP) and Re-ChIP. ChIP was performed as previously described 49 . In brief, both wild-type and Arrb1 2/2 MEFs were incubated with 50 mM etoposide for 20 h. After incubation, cells were treated with 2 mM disuccinimidyl glutarate (Pierce) to crosslink protein complexes, then treated with formaldehyde to link protein to DNA covalently. Cells were lysed and the nucleoprotein complexes were sonicated. DNA-protein complexes enriched by the initial immunoprecipitation with anti-ARRB1 (K-16) antibody were eluted from beads with elution buffer (1% SDS, 0.1 M NaHCO 3 ), and further immunoprecipitated with anti-p53 (FL-393) antibody for Re-ChIP. The retrieved complexes were then analysed by PCR amplification of p53-binding elements in the p21 promoter. Statistics. Unless otherwise noted, P values were calculated with Student's t-test (two-tailed). Analysis of variance was performed with Prism (GraphPad).
